Cantere, Reyna .
HRN: 25-90-52 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/23/2024
CLINDAMYCIN 300MG (CAP)
09/23/2024
09/29/2024
PO
300 Mg
Q8
Sp Completion Curettage
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes